Hyperphosphatemic familial tumoral calcinosis caused by a mutation in GALNT3 in a European kindred
- 10 March 2006
- journal article
- case report
- Published by Springer Nature in Journal of Human Genetics
- Vol. 51 (5), 487-490
- https://doi.org/10.1007/s10038-006-0377-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolismAmerican Journal of Physiology-Renal Physiology, 2005
- A Novel Mutation in Fibroblast Growth Factor 23 Gene as a Cause of Tumoral CalcinosisJournal of Clinical Endocrinology & Metabolism, 2005
- Role of the vitamin D receptor in FGF23 action on phosphate metabolismBiochemical Journal, 2005
- Inhibition of Intestinal Sodium‐dependent Inorganic Phosphate Transport by Fibroblast Growth Factor 23Therapeutic Apheresis and Dialysis, 2005
- Post-translational Modification of Fibroblast Growth Factor 23Therapeutic Apheresis and Dialysis, 2005
- Gains of glycosylation comprise an unexpectedly large group of pathogenic mutationsNature Genetics, 2005
- Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disordersJournal of Molecular Medicine, 2004
- Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosisNature Genetics, 2004
- All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferasesGlycobiology, 2002
- Tumoral Calcinosis--an Unrecognized DiseaseBMJ, 1969